Learn More
Invitrogen™ A4GALT Monoclonal Antibody (38.13), FITC

Description
This antibody recognizes CD77 (globotriaosylceramide Gb3), a neutral glycosphingolipid expressed mainly on the surface of B cell populations, such as germinal center B cells and Burkitt's lymphoma cells.
Specifications
Specifications
| Antigen | A4GALT |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | 38.13 |
| Concentration | 0.260 mg/mL |
| Conjugate | FITC |
| Formulation | TBS with 0.2% BSA and 15mM sodium azide; pH 8 |
| Gene | A4galt |
| Gene Accession No. | Q9NPC4 |
| Gene Alias | A14GALT; A4GALT; A4galt {ECO:0000312; A4GALT1; alpha 1,4-galactosyltransferase; alpha 14-galactosyltransferase; alpha-1,4-galactosyltransferase; Alpha-1,4-N-acetylglucosaminyltransferase; alpha4Gal-T1; cd77; CD77 synthase; Gb3; Gb3 synthase; Gb3/CD77 synthase; Gb3S; Globotriaosylceramide synthase; lac; lactosylceramide 4-alpha-galactosyltransferase; P blood group (P one antigen); P(k); P(k) antigen synthase; P1; P1/Pk synthase; P1PK; PK; RGD:621583}; truncated alpha 1,4-galactosyltransferase; UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.